A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

Local Institution - 0062, Budapest

Local Institution - 0023, Budapest

Local Institution - 0013, Ballarat

Local Institution - 0064, Taipei

Local Institution - 0038, Pittsburgh

Humanitas, Rozzano

Local Institution - 0055, Richmond

Local Institution - 0012, Kiel

Fondazione Irccs - Policlinico San Matteo, Pavia

Local Institution - 0045, Fuenlabrada

Local Institution - 0066, Charleston

Local Institution - 0037, Jackson

Local Institution - 0041, Cleveland

Local Institution - 0002, Wyoming

Local Institution - 0036, Shreveport

Local Institution - 0053, Garland

Local Institution - 0049, Tyler

Local Institution - 0056, San Antonio

Local Institution, Saint Petersburg

Local Institution - 0030, Guangzhou

Local Institution - 0029, Guangzhou

Local Institution, Irkutsk

Local Institution - 0026, Bunkyo-ku

Local Institution - 0027, Saga

Local Institution - 0050, Vaughan

Local Institution - 0063, Hirosaki

Local Institution - 0047, Sagamihara

Local Institution - 0044, Minato-ku

Local Institution - 0060, Amsterdam

Local Institution - 0046, Nowy Targ

Local Institution - 0061, Tychy

Local Institution - 0022, Bydgoszcz

Local Institution - 0003, Bydgoszcz

Local Institution - 0001, Krakow

Local Institution - 0028, Sopot

Local Institution - 0025, Szczecin

Local Institution - 0035, Warsaw

Local Institution - 0048, Warsaw

Local Institution - 0004, Warsaw

Local Institution - 0018, Wroclaw

Local Institution - 0054, Santa Maria da Feira

Local Institution, Bucharest

Local Institution - 0034, Morriston